Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
Journal of Human Genetics|February 17, 2017
Clinical diversity caused by novel IGHMBP2 variantsJun-Hui Yuan, Akihiro Hashiguchi, Akiko Yoshimura, et al.Cerebellum (London, England)|September 9, 2021
Prevalence of Fragile X-Associated Tremor/Ataxia Syndrome in Patients with Cerebellar Ataxia in JapanYujiro Higuchi, Masahiro Ando, Akiko Yoshimura, et al.Neurology. Genetics|October 30, 2025
Frameshift and Copy Number Variants in SACS-Related NeuropathyJun-Hui Yuan, Yujiro Higuchi, Masahiro Ando, et al.Journal of Neurology|June 29, 2026
Genetic spectrum and clinical features of PMP22 point mutations in Japanese Charcot-Marie-Tooth diseaseChikashi Yano, Masahiro Ando, Yujiro Higuchi, et al.Annals of Clinical and Translational Neurology|October 1, 2025
Nationwide Characterization of MFN2-Related CMT in 176 Japanese Patients: Clinical and Genetic InsightsMasahiro Ando, Yujiro Higuchi, Jun-Hui Yuan, et al.Scientific Reports|October 18, 2023
CANVAS-related RFC1 mutations in patients with immune-mediated neuropathyMakito Hirano, Motoi Kuwahara, Yuko Yamagishi, et al.Journal of Human Genetics|January 12, 2018
Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2Jun-Hui Yuan, Akihiro Hashiguchi, Yuji Okamoto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapyAkira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, et al.Anticancer Research|March 14, 2013
Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancerRintaro Noro, Akinobu Yoshimura, Kazuo Yamamoto, et al.Journal of Neurology|September 26, 2023
Dystonia and Parkinsonism in COA7-related disorders: expanding the phenotypic spectrumYujiro Higuchi, Masahiro Ando, Fumikazu Kojima, et al.Pageof 12